Literature DB >> 22644993

Isolated splenic metastasis from carcinoma of the breast: a case report.

Kari Sufficool1, Jeff Wang, Sean Doherty.   

Abstract

Breast carcinoma with visceral metastasis to the lungs, liver, and bone is common. However, isolated splenic metastases from breast carcinoma are rare. This has been rarely described in the medical literature. This case report presents a 48-year-old woman with newly diagnosed breast cancer and an isolated splenic metastasis diagnosed by ultrasound-guided fine-needle aspiration (FNA). Radiologic staging revealed no involvement of other organs, such as lungs, liver, or bone. The pathogenesis of rare single splenic metastasis and the diagnostic role of FNA on the spleen lesion are discussed. This case is being reported due to its rare metastatic initial presentation and the role of FNA in achieving the diagnosis.
Copyright © 2012 Wiley Periodicals, Inc., a Wiley company.

Entities:  

Keywords:  breast cancer; cytology; fine-needle aspiration; metastasis; splenic lesion

Mesh:

Year:  2012        PMID: 22644993     DOI: 10.1002/dc.22860

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  3 in total

1.  Splenic metastasis of breast cancer: A rare metastatic site depicted on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.

Authors:  Tarik Elri; Mustafa Aras; Yavuz Sami Salihoglu; Mehmet Cabuk
Journal:  Indian J Nucl Med       Date:  2015 Oct-Dec

2.  Case report: solitary splenic metastasis occurring 19 months after primary treatment for occult breast cancer.

Authors:  Yuanqi Chen; Liulu Zhang; Taotao Sun; Min-Yi Cheng; Jiachen Zou; Kun Wang
Journal:  Front Oncol       Date:  2022-07-28       Impact factor: 5.738

Review 3.  Rare sites of breast cancer metastasis: a review.

Authors:  Rosa Di Micco; Letizia Santurro; Maria Luisa Gasparri; Veronica Zuber; Enrico Fiacco; Guglielmo Gazzetta; Chanel Elisha Smart; Alice Valentini; Oreste Davide Gentilini
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.